[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]  Darp101 [@DarpResearch](/creator/twitter/DarpResearch) on x XXX followers Created: 2025-07-03 21:33:59 UTC More good news. I have talked to someone else at $NGENF now, and they do understand the problem of public perception of just how positive the results were, and also simple awareness of the drug trial itself. My biggest concern was if they had an opportunity to get major news coverage, they might turn it down, not at all—we discussed how to get major coverage in the press and podcasts. I will do my best to assist them on this. There is one thing they cannot do, but we can. I have no doubt that Larry Williams going from XXX feet with a walker after treatment with the drug to over a mile now means that once the nerve gets past the glial scar, it just keeps going. Dr. Jerry Silver predicted this (he is the inventor of the NVG-291 technology). However NervGen can only talk about what happened during the trial period. So it is up to us to connect the dots and get that info out there. If a medical podcaster asks patients about that and points out this indicates a major benefit from NVG-291 after treatment ends, that is fine. We can post about it, but NervGen cannot talk about that. The bottom line is I am very encouraged we can solve the awareness issue and am glad I bought about XXXXXX more shares today before calling NervGen today. How I see it is the company is derisked hugely, and the share price has only factored in a fraction of that derisking. I think it is a steal here. Cheers XXX engagements  **Related Topics** [$ngenf](/topic/$ngenf) [Post Link](https://x.com/DarpResearch/status/1940886766338429273)
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Darp101 @DarpResearch on x XXX followers
Created: 2025-07-03 21:33:59 UTC
More good news. I have talked to someone else at $NGENF now, and they do understand the problem of public perception of just how positive the results were, and also simple awareness of the drug trial itself. My biggest concern was if they had an opportunity to get major news coverage, they might turn it down, not at all—we discussed how to get major coverage in the press and podcasts. I will do my best to assist them on this.
There is one thing they cannot do, but we can. I have no doubt that Larry Williams going from XXX feet with a walker after treatment with the drug to over a mile now means that once the nerve gets past the glial scar, it just keeps going. Dr. Jerry Silver predicted this (he is the inventor of the NVG-291 technology). However NervGen can only talk about what happened during the trial period. So it is up to us to connect the dots and get that info out there. If a medical podcaster asks patients about that and points out this indicates a major benefit from NVG-291 after treatment ends, that is fine. We can post about it, but NervGen cannot talk about that.
The bottom line is I am very encouraged we can solve the awareness issue and am glad I bought about XXXXXX more shares today before calling NervGen today. How I see it is the company is derisked hugely, and the share price has only factored in a fraction of that derisking. I think it is a steal here. Cheers
XXX engagements
Related Topics $ngenf